Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

560 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Gemcitabine-cisplatin: a schedule finding study.
Kroep JR, Peters GJ, van Moorsel CJ, Catik A, Vermorken JB, Pinedo HM, van Groeningen CJ. Kroep JR, et al. Among authors: vermorken jb. Ann Oncol. 1999 Dec;10(12):1503-10. doi: 10.1023/a:1008339425708. Ann Oncol. 1999. PMID: 10643544 Free article. Clinical Trial.
Paclitaxel-induced neuropathy.
Postma TJ, Vermorken JB, Liefting AJ, Pinedo HM, Heimans JJ. Postma TJ, et al. Among authors: vermorken jb. Ann Oncol. 1995 May;6(5):489-94. doi: 10.1093/oxfordjournals.annonc.a059220. Ann Oncol. 1995. PMID: 7669713 Free article. Clinical Trial.
A double-blind randomized crossover study to compare the antiemetic efficacy of 250 mg with 500 mg methylprednisolone succinate (Solu-Medrol) as a single intravenous dose in patients treated with noncisplatin chemotherapy.
Pieters RC, Vermorken JB, Gall HE, Nauta JJ, van Loenen AC, van Groeningen CJ, van Rijswijk RE, Brenninkmeijer JH, Pinedo HM. Pieters RC, et al. Among authors: vermorken jb. Oncology. 1993 Jul-Aug;50(4):316-22. doi: 10.1159/000227202. Oncology. 1993. PMID: 8497383 Clinical Trial.
Pharmacokinetics of paclitaxel and three major metabolites in patients with advanced breast carcinoma refractory to anthracycline therapy treated with a 3-hour paclitaxel infusion: a European Cancer Centre (ECC) trial.
Huizing MT, Vermorken JB, Rosing H, ten Bokkel Huinink WW, Mandjes I, Pinedo HM, Beijnen JH. Huizing MT, et al. Among authors: vermorken jb. Ann Oncol. 1995 Sep;6(7):699-704. doi: 10.1093/oxfordjournals.annonc.a059287. Ann Oncol. 1995. PMID: 8664192 Free article. Clinical Trial.
Combination chemotherapy studies with gemcitabine.
van Moorsel CJ, Veerman G, Bergman AM, Guechev A, Vermorken JB, Postmus PE, Peters GJ. van Moorsel CJ, et al. Among authors: vermorken jb. Semin Oncol. 1997 Apr;24(2 Suppl 7):S7-17-S7-23. Semin Oncol. 1997. PMID: 9194475 Review.
Multiple cycles of high-dose doxorubicin and cyclophosphamide with G-CSF mobilized peripheral blood progenitor cell support in patients with metastatic breast cancer.
Honkoop AH, van der Wall E, Feller N, Schuurhuis GJ, van der Vijgh WJ, Boven E, van Groeningen CJ, Giaccone G, Hoekman K, Vermorken JB, Wagstaff J, Pinedo HM. Honkoop AH, et al. Among authors: vermorken jb. Ann Oncol. 1997 Oct;8(10):957-62. doi: 10.1023/a:1008259518263. Ann Oncol. 1997. PMID: 9402167 Free article.
Mechanisms of synergism between gemcitabine and cisplatin.
van Moorsel CJ, Veerman G, Vermorken JB, Voorn DA, Kroep JR, Bergman AM, Pinedo HM, Peters GJ. van Moorsel CJ, et al. Among authors: vermorken jb. Adv Exp Med Biol. 1998;431:581-5. doi: 10.1007/978-1-4615-5381-6_112. Adv Exp Med Biol. 1998. PMID: 9598132 Clinical Trial. No abstract available.
560 results